key: cord-0733993-qjppsbqj
authors: Khezri, Mohammad Rafi; Ghasemnejad-Berenji, Morteza
title: Neurological effects of elevated levels of angiotensin II in COVID-19 patients
date: 2021-08-27
journal: Hum Cell
DOI: 10.1007/s13577-021-00605-0
sha: 0e3322cf7455d4feafb3a59aa20e7b4139180f93
doc_id: 733993
cord_uid: qjppsbqj

nan

and hemorrhage has been reported in patients treated with thrombolytic drugs [6] . On the other hand, following the entry of the virus into the brain [5] , it may cause endocytosis of ACE2 leading to an increase in the levels of cerebral Ang II, which by binding to its receptors on astrocytes can cause the expression of inflammatory cytokines [7] . On the other hand, elevated levels of Ang II may contribute to neuronal loss in different parts of the brain. It has been shown that Ang II causes dopaminergic neurons death and losartan, an AT1R antagonist, protects these neurons against apoptosis [8] . In addition, the association between Ang II and Alzheimer's disease is examined in different studies. For instance, it has been indicated that ACE2 is decreased in Alzheimer's disease leading to increase tau pathology [9] . In addition, Ang II has been shown to increase brain Aβ through modulation of amyloid precursor protein production and α-, β-, and γ-secretase activities in an animal model of Alzheimer's disease [10] . Overall, based on the available evidence, the effect of the SARS-CoV-2 on elevated Ang II levels should be given more attention and further studies in this field can be constructive.

Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?

SARS-CoV-2 infectivity and neurological targets in the brain

Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients

Compromised blood-brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension

Neuroinvasion of SARS-CoV-2 in human and mouse brain

Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke

Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensinconverting enzyme 2 in rat astrocytes

Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra

Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology. Alzheimer's Res Ther

Central angiotensin II stimulation promotes β amyloid production in Sprague Dawley rats